Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:51 pm Purchase | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | Nantahala Capital Management LLC | 1,214,094 5.1% | 1,214,094 (New Position) | View |
| 2024-01-11 1:04 pm Purchase | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | LYTTON LAURENCE W | 1,304,102 5.2% | 1,304,102 (New Position) | View |
| 2023-08-01 7:04 pm Purchase | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | MANCHESTER MANAGEMENT CO LLC | 2,438,126 9.999% | 2,438,126 (New Position) | View |
| 2021-01-21 11:27 am Purchase | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | MANCHESTER MANAGEMENT CO LLC | 4,992,951 14.1% | 4,992,951 (New Position) | View |
| 2020-03-27 5:26 pm Sale | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH | 572,846 5% | -287,130 (-33.39%) | View |
| 2019-10-28 6:16 pm Sale | 13D | NEUROONE MED TECHNOLOGIES CORP NMTC | Fredrickson Wade | 2,113,459 15.7% | -500,000 (-19.13%) | View |